ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal…
ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal Solution
- Published
- 12 Feb 2025
- Units affected
- 44,397 amber glass vials
- Agency
- FDA
- Country
- United States
The hazard
Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01
- Brand / company
- ENDO USA, Inc.
- Codes / lots
- All lots within expiry
- Distribution
- USA nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.